Bill
SB 253
Killed bill would have allowed New Hampshire healthcare providers to access federal drug discounts for uninsured patients through the 340B program.
SB 253 would have enabled New Hampshire to participate in the federal 340B Drug Pricing Program, which allows certain healthcare entities (hospitals, clinics, and patient assistance programs) to purchase covered outpatient drugs at significant discounts from manufacturers. The bill aimed to expand access to this program for eligible New Hampshire providers, potentially reducing drug costs for uninsured and underinsured patients.
The 340B program can meaningfully lower medication costs for vulnerable populations by allowing healthcare providers to purchase drugs at 20-40% discounts and reinvest savings into patient care services. Participation could have expanded affordable drug access across New Hampshire's healthcare system, particularly benefiting safety-net hospitals and community health centers serving low-income patients.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
